Welcome to our dedicated page for Artius II Acquisition SEC filings (Ticker: AACB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Artius II Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Artius II Acquisition's regulatory disclosures and financial reporting.
Healthcare of Ontario Pension Plan Trust Fund (HOOPP) filed an amended Schedule 13G reporting its beneficial ownership of Artius II Acquisition Inc. Class A ordinary shares. HOOPP holds 850,000 Class A shares, representing 3.8% of this share class, based on 22,175,000 shares outstanding as of November 6, 2025.
HOOPP reports sole voting and dispositive power over all 850,000 shares and no shared power. It certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Artius II Acquisition Inc.
Artius II Acquisition Inc. (AACB) filed its Q3 2025 report, showing a SPAC still in its search phase with sizeable funds in trust and standard SPAC expenses. The trust held $225,851,431 as of September 30, 2025, invested primarily in short‑term U.S. Treasuries. For the quarter, the company recorded net income of $2,210,556, driven by $2,451,396 of interest income; year‑to‑date results reflect a net loss of $750,481 after recognizing a $6,000,000 advisory fee.
The SPAC completed its IPO on February 14, 2025, issuing 22,000,000 units for gross proceeds of $220,000,000, alongside 175,000 private placement units for $1,750,000. Transaction costs totaled $7,537,261, including a deferred underwriting fee of $6,600,000. Cash outside the trust was $141,921 with a working capital surplus of $98,807 as of quarter‑end.
The company has until August 14, 2026 (or February 14, 2027 if a definitive agreement is executed) to consummate a business combination. Management disclosed that these timelines and limited operating cash raise substantial doubt about the company’s ability to continue as a going concern absent a completed transaction.